CoChat

Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility

Hegele, Robert A., Breslow, Jan L., Cloninger, C. Robert · 1987 · Genetic Epidemiology

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Abstract

Apolipoproteins are the protein constituents of lipoproteins, the particles that transport cholesterol and triglycerides in the plasma. Numerous epidemiologic studies have associated variations in plasma levels of lipoproteins and apolipoproteins with the development of atherosclerosis. Furthermore, genetic variations in lipoproteins and apolipoproteins have been associated with disorders of lipid metabolism. Recent advances in biochemical and molecular genetic methods have resulted in an increased understanding of interindividual variations in lipoprotein metabolism and of their relationship to atherosclerosis and the dyslipoproteinemias. In particular, certain DNA restriction fragment length polymorphisms of the apolipoprotein genes have, in the last few years, been associated with atherosclerotic diseases and dyslipoproteinemias. We believe that genetic markers, when used in conjunction with traditional clinical and biochemical determinations, may one day be useful in predicting atherosclerosis susceptibility in the general population.

Overview

Integrity signals

Registry

Crossref · 10.1002/gepi.1370040302

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 80 references

Research works printed but not linked: 21

  1. Anderson RA, 1986, Apolipoprotein A‐I gene locus haplotypes and HDL‐cholesterol levels, Clin Res, 34, 889A
  2. Anderson RA, 1985, Apoprotein A‐I linked genetic polymorphisms associated with high density lipoprotein levels, Clin Res, 33, 15
  3. Antonarakis SE, 1986, DNA polymorphism of the human apolipoprotein AI‐CIII‐AIV gene cluster, Am J Hum Genet (Suppl)., 39, 549
  4. Assmann G, 1986, Lack of association between RFLPs of the human apolipoprotein CII gene locus and clinical manifestations of atherosclerosis, Am J Hum Genet (Suppl)., 39, 260
  5. Avogaro P, 1978, Plasma levels of apolipoprotein AI and apoprotein B in human atherosclerosis, Artery., 4, 385
  6. Chen CH, 1983, Enhancement of Apolipoprotein Ai‐Activated Human Plasma Lecithin: Cholesterol Acyl Transferase Activity by Apoprotein Aii, Arteriosclerosis., 3, 489a
  7. Cole SA, 1986, A population genetics study of apolipoprotein AI gene polymorphism, Am J Hum Genet (Suppl)., 39, 691
  8. DHHS, 1980, Lipid Research Clinics Population Studies Data Book. The Prevalence Study, 28
  9. Fojo SS, 1986, Analysis of apo C‐II patients with apo C‐II deficiency, Circulation, 74, 284
  10. FrossardP ColemanR FunkeH AssmannG(1985):Molecular genetics of the human apolipoprotein AI‐CIII gene complex: Application to detection of susceptibility to atherosclerosis. In “Proceedings of the 4th International Atherosclerosis Symposium.” Munster GDR.
  11. Frossard PM, 1986, Genetic markers for coronary atherosclerosis in the human apolipoprotein AI‐CIII‐AIV gene complex, Am J Hum Genet (Suppl)., 39, 589
  12. Havekes L, 1986, The apolipoprotein E polymorphism at the DNA level, Circulation, 74, 322
  13. Karathanasis SK, 1986, DNA inversion inactivates both the apo AI and apo CIII genes in patients with combined apo AI‐apo CIII deficiency and premature coronary artery disease, Circulation, 74, 157
  14. Karathanasis SK, 1984, Apo CIII gene defect in patients with combined apo A‐I‐CIII deficiency and premature atherosclerosis, Arteriosclerosis, 4, 562a
  15. Kostner GM, 1986, The interactional of lipoproteina with glycosaminoglycans: Possible mechanism for its atherogenicity, Circulation, 74, 25
  16. Lim D, 1986, Deletion of an Alu sequence in the 5′ of the apolipoprotein AI gene associated with decreased serum HDL‐cholesterol levels, Am J Hum Genet (Suppl)., 39, 621
  17. Menzel HJ, 1984, Human apolipoprotein A‐I gene polymorphism, J Biol Chem, 259, 3070
  18. Schaefer EJ, 1986, Apolipoprotein E isoforms in the Framingham Offspring Study: Significance of variant alleles, Circulation, 74, 202
  19. Schulte H, 1986, The MspI RFLP 3′ to the human apolipoprotein AII gene is neutral with respect to atherosclerosis in Germans, Am J Hum Genet (Suppl)., 39, 293
  20. Scott J, 1985, High density lipoprotein composition is altered by a common DNA polymorphism adjacent to apolipoprotein A‐II gene in man, Lancet, 1, 770
  21. Weisgraber KH, 1986, Apolipoprotein B heparin binding sites: Insights into the receptor binding domain, Circulation, 74, 106

Cited by

Metadata

Authors
Hegele, R. A., Breslow, J. L., & Cloninger, C. R.
Affiliations
Rockefeller University (US)
Corresponding author
Breslow, Jan L.
Venue
Genetic Epidemiology
Publisher
Wiley
Published
1987-01
Volume
4
Issue
3
Pages
163-184
ISSN
  • 0741-0395 (ISSN-L)
  • 1098-2272
OpenAlex
W1729623267
Cited by
60
References
79
Citations by year
2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 1 · 2013: 2 · 2012: 1
FWCI
12.28
Type
journal article
Language
en
Open access
closed
Locations
  • Genetic Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
apolipoproteins, atherosclerosis susceptibility, genetic variation, restriction fragment length polymorphism, apolipoprotein genes, dyslipoproteinemia, lipid metabolism disorders, genetic markers, lipoprotein metabolism, cardiovascular risk prediction
MeSH terms
Apolipoproteins, Arteriosclerosis, Chromosome Mapping, Disease Susceptibility, Genes, Humans, Polymorphism, Restriction Fragment Length, Genetic Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.